|
BioPharm America 2017, Sep. 26-27, Boston, MA
|
5
|
Resverlogix Corp.
|
Sep 16, 2017 11:36AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
4
|
Zenith Epigenetics
|
Sep 16, 2017 02:19PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
3
|
Zenith Epigenetics
|
Sep 17, 2017 09:28PM
|
|
Tailwinds Research Group "biOasis Breaking Out of Downtrend?"
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 18, 2017 10:43AM
|
|
Article on MOA of BET inhibition restoring sensitivity to anti-androgen therapy
|
4
|
Zenith Epigenetics
|
Sep 18, 2017 02:21PM
|
|
Bioasis Announces Rob Hutchison, Founder, to Retire as Chairman & Board Member
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 18, 2017 02:29PM
|
|
Re: Bioasis Announces Rob Hutchison, Founder, to Retire as Chairman & Board Member
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 18, 2017 04:43PM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
4
|
Zenith Epigenetics
|
Sep 19, 2017 07:56AM
|
|
Re: FA
|
2
|
Resverlogix Corp.
|
Sep 19, 2017 04:13PM
|
|
Re: FA expectations
|
5
|
Resverlogix Corp.
|
Sep 19, 2017 05:09PM
|
|
Re: Huge profit taking today on the "pinks"
|
|
BIOASIS TECHNOLOGIES INC
|
Sep 20, 2017 04:04PM
|
|
Re: ALNY/BTI
|
2
|
BIOASIS TECHNOLOGIES INC
|
Sep 21, 2017 10:16AM
|
|
Re: Has Kenneth Lebioda done presentations before?
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 07:03AM
|
|
Re: Demoralizing....
|
1
|
Resverlogix Corp.
|
Sep 22, 2017 07:05AM
|
|
Re: Demoralizing....
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 10:17AM
|
|
Re: Resverlogix now listed as a Presenting Company at Biopharm America
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 10:26AM
|
|
Re: ZEN-3694 Single Agent Trial Status
|
2
|
Zenith Epigenetics
|
Sep 22, 2017 10:30AM
|
|
Re: Has Kenneth Lebioda done presentations before?
|
4
|
Resverlogix Corp.
|
Sep 22, 2017 10:43AM
|
|
Re: Resverlogix now listed as a Presenting Company at Biopharm America
|
1
|
Resverlogix Corp.
|
Sep 22, 2017 12:02PM
|
|
Mark Day Panelist at RESI 2017 Early Stage Therapeutics Panel
|
1
|
BIOASIS TECHNOLOGIES INC
|
Sep 23, 2017 05:30PM
|
